Evaluation of a Serum-Free Medium for Human Epithelial and Stromal Cell Culture.

cell culture cellular morphology clonogenicity metabolism proliferation serum-containing medium serum-free medium

Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
02 Sep 2022
Historique:
received: 01 08 2022
revised: 27 08 2022
accepted: 31 08 2022
entrez: 9 9 2022
pubmed: 10 9 2022
medline: 14 9 2022
Statut: epublish

Résumé

Over the past decade, growing demand from many domains (research, cosmetics, pharmaceutical industries, etc.) has given rise to significant expansion of the number of in vitro cell cultures. Despite the widespread use of fetal bovine serum, many issues remain. Among them, the whole constitution of most serums remains unknown and is subject to significant variations. Furthermore, the presence of potential contamination and xenogeny elements is challenging for clinical applications, while limited production is an obstacle to the growing demand. To circumvent these issues, a Serum-Free Medium (SFM) has been developed to culture dermal and vesical fibroblasts and their corresponding epithelial cells, namely, keratinocytes and urothelial cells. To assess the impact of SFM on these cells, proliferation, clonogenic and metabolic assays have been compared over three passages to conditions associated with the use of a classic Fetal Bovine Serum-Containing Medium (FBSCM). The results showed that the SFM enabled fibroblast and epithelial cell proliferation while maintaining a morphology, cell size and metabolism similar to those of FBSCM. SFM has repeatedly been found to be better suited for epithelial cell proliferation and clonogenicity. Fibroblasts and epithelial cells also showed more significant mitochondrial metabolism in the SFM compared to the FBSCM condition. However, the SFM may need further optimization to improve fibroblast proliferation.

Identifiants

pubmed: 36077429
pii: ijms231710035
doi: 10.3390/ijms231710035
pmc: PMC9455993
pii:
doi:

Substances chimiques

Culture Media, Serum-Free 0
Serum Albumin, Bovine 27432CM55Q

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Fond de Recherche du Québec Santé
ID : 290719
Organisme : Canadian Urological Association scholarship fund
Organisme : CIHR
ID : 258229
Pays : Canada

Références

Theranostics. 2021 Jul 13;11(17):8322-8336
pubmed: 34373744
Biomaterials. 2017 Nov;145:233-241
pubmed: 28888113
Sci Rep. 2020 Jun 9;10(1):9291
pubmed: 32518266
Stem Cell Res Ther. 2022 Apr 4;13(1):142
pubmed: 35379348
Proc Natl Acad Sci U S A. 1987 Apr;84(8):2302-6
pubmed: 2436229
Cytotechnology. 2013 Oct;65(5):791-3
pubmed: 23975256
Cell Cycle. 2009 Dec;8(23):3984-4001
pubmed: 19923890
Mol Cancer Res. 2018 Jul;16(7):1196-1204
pubmed: 29636362
ALTEX. 2003;20(4):275-81
pubmed: 14671707
Stem Cell Res Ther. 2018 Mar 22;9(1):75
pubmed: 29566772
Sci Rep. 2021 Feb 9;11(1):3403
pubmed: 33564114
Cancers (Basel). 2021 Oct 30;13(21):
pubmed: 34771623
Diabetes. 2007 Jun;56(6):1592-9
pubmed: 17351150
Stem Cells. 2006 Feb;24(2):368-75
pubmed: 16123387
PLoS One. 2019 Feb 27;14(2):e0210250
pubmed: 30811421
J Cell Physiol. 1987 Jul;132(1):125-30
pubmed: 3597549
Int J Immunopathol Pharmacol. 2009 Apr-Jun;22(2):485-92
pubmed: 19505400
Cytotherapy. 2017 Feb;19(2):155-169
pubmed: 28017599
In Vitro Cell Dev Biol Anim. 1995 Jun;31(6):432-9
pubmed: 8589886
Wound Repair Regen. 2008 Mar-Apr;16(2):274-87
pubmed: 18282267
PLoS One. 2012;7(5):e37839
pubmed: 22662236
Regen Med. 2012 Jan;7(1):7-13
pubmed: 22168489
Stem Cells. 2007 May;25(5):1270-8
pubmed: 17255520
In Vitro. 1971 Nov-Dec;7(3):174-89
pubmed: 4131329
Stem Cell Res Ther. 2022 Mar 25;13(1):125
pubmed: 35337377
Cell Tissue Bank. 2022 May 30;:
pubmed: 35635634
Int Rev Cytol. 2007;257:143-79
pubmed: 17280897
Biomed Mater Eng. 2009;19(4-5):365-72
pubmed: 20042803
In Vitro Cell Dev Biol Anim. 2009 Sep;45(8):430-41
pubmed: 19533257
Biochem Soc Trans. 2009 Dec;37(Pt 6):1385-8
pubmed: 19909281
Stem Cell Res Ther. 2010 Apr 02;1(1):8
pubmed: 20504289
Int J Mol Sci. 2013 Feb 26;14(3):4684-704
pubmed: 23443166
Methods Mol Biol. 2017;1601:79-87
pubmed: 28470519
Methods Mol Biol. 2018;1686:27-47
pubmed: 29030810
Bioessays. 2016 Jul;38 Suppl 1:S136-45
pubmed: 27417117
Methods Enzymol. 2014;542:125-49
pubmed: 24862264
J Tissue Eng Regen Med. 2017 Nov;11(11):3090-3099
pubmed: 28156053
Int J Hyg Environ Health. 2002 Apr;205(3):235-8
pubmed: 12040921
Bioengineering (Basel). 2021 Nov 13;8(11):
pubmed: 34821750
J Exp Clin Cancer Res. 2015 Oct 06;34:111
pubmed: 26445347
Altern Lab Anim. 2002 Mar-Apr;30(2):219-27
pubmed: 11971757
Matrix. 1993 Nov;13(6):441-6
pubmed: 8309423
J Wound Care. 2013 Aug;22(8):407-8, 410-12
pubmed: 23924840

Auteurs

Christophe Caneparo (C)

Centre de Recherche en Organogénèse Expérimentale de l'Université Laval/LOEX, Axe Médecine Régénératrice, Centre de Recherche du CHU de Québec-Université Laval, Quebec, QC G1J 1Z4, Canada.

Stéphane Chabaud (S)

Centre de Recherche en Organogénèse Expérimentale de l'Université Laval/LOEX, Axe Médecine Régénératrice, Centre de Recherche du CHU de Québec-Université Laval, Quebec, QC G1J 1Z4, Canada.
Centre de Recherche sur le Cancer, Université Laval, Quebec, QC G1R 3S3, Canada.

Julie Fradette (J)

Centre de Recherche en Organogénèse Expérimentale de l'Université Laval/LOEX, Axe Médecine Régénératrice, Centre de Recherche du CHU de Québec-Université Laval, Quebec, QC G1J 1Z4, Canada.
Department of Surgery, Faculty of Medicine, Université Laval, Quebec, QC G1V 0A6, Canada.

Stéphane Bolduc (S)

Centre de Recherche en Organogénèse Expérimentale de l'Université Laval/LOEX, Axe Médecine Régénératrice, Centre de Recherche du CHU de Québec-Université Laval, Quebec, QC G1J 1Z4, Canada.
Centre de Recherche sur le Cancer, Université Laval, Quebec, QC G1R 3S3, Canada.
Department of Surgery, Faculty of Medicine, Université Laval, Quebec, QC G1V 0A6, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH